Viagra, Lyrica among 91 meds to get June price hikes at Pfizer: FT

Fierce Pharma ------ Defying industrywide pricing criticism, Pfizer has raised the U.S. prices on 91 medicines by an average of 20% so far this year, according to the Financial Times. The hikes come as a debate wages on over the industry’s tactics and as Congress has yet to take action on the issue. Among the Pfizer meds to get a price increase in June were erectile dysfunction drug Viagra—which jumped 27.5% so far this year after hikes in January and June—and nerve pain med Lyrica, a top seller for the New York drug giant, according to FT. A Pfizer spokesperson said the company "has always priced responsibly," adding that "innovative medicines are one of the most valuable and cost effective segments of healthcare spend and are an important part of the solution to growing healthcare costs." The drugmaker's average prices after discounts have increased by 4% this year, he pointed out. To learn more click on the picture below to read the article.